J. Thelander Consulting and the BIA: an exclusive partnership
This collaboration marks the commencement of our UK Private Company Compensation Initiative, aimed at enhancing compensation transparency for privately held life science companies in the UK and beyond.
In this blog post, J.Thelander introduce themselves and talk in more detail about their partnership with the BIA.
Who is J.Thelander Consulting?
For nearly three decades, J.Thelander Consulting has been the global leader for private company and investment firm compensation data, insights and analysis. We survey more than 5,000 venture capital, private equity, corporate venture firms and their portfolio companies annually on all aspects of their compensation through an online survey that goes directly to the companies or firms to complete. The survey covers more than 300 positions across C-Suite, VPs, Directors, Managers, Staff-Level Positions and Outside/Independent Board Members. The results are delivered swiftly and in real-time, within one day of submission.
We ensure confidentiality with all participants and firms. Our data is published in aggregate only with no individual company names shared and the data is never shared with any third parties. This method provides an unparalleled depth of insight, helping companies and investment firms level up their compensation strategy.
Our innovative platform offers more than just real-time data—it includes comprehensive reports on option pool, non-investor/outside board member compensation, salary increases, carve-out plans, and more. With a “My Data Column,” companies can compare their compensation to market, based on industry, total financing, series of financing, valuation, revenue, and/or geography. All of our data tables are fully customizable and our platform is intuitive, providing instant feedback to help companies and investors make informed decisions quickly and reliably.
The partnership explained
Our partnership with BIA is designed to equip UK-based life science companies with the tools needed to make informed decisions as they navigate the complexities of raising capital and scaling operations (within the UK and the United States). Through the UK Private Company Compensation Initiative, we offer real-time compensation data and insights that are crucial for developing competitive and equitable compensation packages that attract and retain top talent.
Ros Deegan, CEO of Omass Therapeutics and a Board Member at the BioIndustry Association, praises the initiative:
We have chosen the Thelander platform because it has the best functionality for private companies and if we can spread the word and get others to input their data, we can get a fantastic set of benchmarking data for private UK biotech.
Participate in the Thelander Private Company Compensation Survey today for free access to a subset of the results
We invite you to contribute to shaping the landscape of life science compensation by participating in the no-cost Thelander Private Company Compensation Survey to secure free compensation data for eighty titles. Your involvement will provide you with a complimentary subscription to the Thelander platform and also ensure your compensation is in line with privately held companies in the same industry, financing, region and more. If you complete your response by September 30, you will receive a complimentary 30 minute session to discuss your compensation strategy and philosophy with Jody and/or Morgan Thelander. Don’t miss this opportunity to influence and access vital compensation data - participate today: Thelander Compensation Survey
Below is a sample of data from the initiative.
*Thelander total cash equals base salary plus current bonus, or only base salary if no bonus was awarded.
